http://www.theguardian.com/world/2015/jan/23/ebola-vaccine-liberia-gsk-glaxosmithkline-trials
GSK hopes to enrol 30,000 people in first large-scale trials of the vaccine, which uses a type of chimpanzee cold virus
Dr Jeremy Farrar, director of the Wellcome Trust, which is funding a trial of the vaccine in UK and Mali and parallel studies of other vaccines in Geneva, Gabon, Kenya and Guinea, said: “This week we’ve heard encouraging news from west Africa, indicating that we may at last have reached a turning point in what has been the worst Ebola outbreak in history. Mali has been declared free from the disease and schools in Guinea reopened, restoring some sense of normality for those communities.
EbolaInfo 